Business
Press Release Aug 19 2025
Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled "Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg".
About this update from Alembic Pharmaceuticals Limited
[{"type":"text","content":" Alembic Pharmaceuticals Limited has informed the Exchange regarding a press release dated August 19, 2025, titled \"Alembic Pharmaceuticals Limited receives USFDA Final Approval for Macitentan Tablets, 10 mg\". View Attachment","length":379,"tagName":"div"}]